207 related articles for article (PubMed ID: 3857118)
21. Induction of differentiation in HL-60 promyelocytic cells: a comparative study in two sublines.
Kaplinsky C; Estrov Z; Freedman MH; Cohen A
Blood Cells; 1986; 11(3):459-68. PubMed ID: 3461855
[TBL] [Abstract][Full Text] [Related]
22. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
23. Resistance of HL-60 promyelocytic leukemia cells to induction of differentiation and its reversal by combination treatment.
Schwartsmann G; Pinedo HM; Leyva A
Eur J Cancer Clin Oncol; 1987 Jun; 23(6):739-43. PubMed ID: 2443360
[TBL] [Abstract][Full Text] [Related]
24. Commitment to differentiation of human promyelocytic leukemia cells (HL60): an all-or-none event preceded by reversible losses of self-renewal potential.
von Melchner H; Höffken K
J Cell Physiol; 1985 Dec; 125(3):573-81. PubMed ID: 3864784
[TBL] [Abstract][Full Text] [Related]
25. Expression of granulocytic functions by leukemic promyelocytic HL-60 cells: differential induction by dimethylsulfoxide and retinoic acid.
Matzner Y; Gavison R; Rachmilewitz EA; Fibach E
Cell Differ; 1987 Sep; 21(4):261-9. PubMed ID: 3476206
[TBL] [Abstract][Full Text] [Related]
26. Retinoic acid-induced monocytic differentiation of HL60/MRI, a cell line derived from a transplantable HL60 tumor.
Imaizumi M; Uozumi J; Breitman TR
Cancer Res; 1987 Mar; 47(5):1434-40. PubMed ID: 3469018
[TBL] [Abstract][Full Text] [Related]
27. New facts and speculations on human myeloid leukemias.
Breitman TR; Gallo RC
Blood Cells; 1981; 7(1):79-89. PubMed ID: 6964818
[TBL] [Abstract][Full Text] [Related]
28. Glycosyltransferase alterations are cell type related when human promyelocytic leukemia (HL-60) cells are treated with various inducers of differentiation.
Liu CK; Schmied R; Schreiber C; Rosen A; Qian GX; Waxman S
Exp Hematol; 1983 Sep; 11(8):738-46. PubMed ID: 6414838
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of sterol and phospholipid synthesis in HL-60 promyelocytic leukemia cells by inducers of myeloid differentiation.
Cooper RA; Ip SH; Cassileth PA; Kuo AL
Cancer Res; 1981 May; 41(5):1847-52. PubMed ID: 6938303
[TBL] [Abstract][Full Text] [Related]
30. [Changes of fibrinolytic activity of human HL60 acute leukemia cells responses to chemically induced differentiation].
Ghezzo F; Palumbo A; Pegoraro L
Boll Soc Ital Biol Sper; 1980 Jul; 56(13):1355-9. PubMed ID: 6934784
[TBL] [Abstract][Full Text] [Related]
31. Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells.
Frank DA; Sartorelli AC
Cancer Res; 1988 Jan; 48(1):52-8. PubMed ID: 2825968
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxicity of human beta-interferon for differentiating leukemic HL-60 cells.
Hamburger AW; White CP; Siebenlist RE; Sedmak JJ; Grossberg SE
Cancer Res; 1985 Nov; 45(11 Pt 1):5369-73. PubMed ID: 2996760
[TBL] [Abstract][Full Text] [Related]
33. Molecular and cellular mechanisms of leukemic hemopoietic cell differentiation: an analysis of the Friend system.
Tsiftsoglou AS; Wong W
Anticancer Res; 1985; 5(1):81-99. PubMed ID: 3888045
[TBL] [Abstract][Full Text] [Related]
34. Induction of proliferation and NK activity in human lymphocytes by mature myelomonocytic cells: evidence for an HLA-DR-independent MLR stimulatory ability of terminally differentiated nonlymphoid leukemic cell lines and of normal peripheral blood granulocytes.
Santoli D; Francis MK; Matera L; Ferrero D
J Immunol; 1983 Aug; 131(2):736-42. PubMed ID: 6306106
[TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukemia cells by anthracyclines.
Schwartz EL; Sartorelli AC
Cancer Res; 1982 Jul; 42(7):2651-5. PubMed ID: 6952957
[TBL] [Abstract][Full Text] [Related]
36. Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line.
Lucas DL; Webster HK; Wright DG
J Clin Invest; 1983 Dec; 72(6):1889-900. PubMed ID: 6139386
[TBL] [Abstract][Full Text] [Related]
37. Synergistic effects of curcumin on all-trans retinoic acid- and 1 alpha,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic leukemia HL-60 cells.
Liu Y; Chang RL; Cui XX; Newmark HL; Conney AH
Oncol Res; 1997; 9(1):19-29. PubMed ID: 9112257
[TBL] [Abstract][Full Text] [Related]
38. Thrombomodulin induction by all-trans retinoic acid is independent of HL-60 cells differentiation to neutrophilic cells.
Kizaki K; Ishii H; Horie S; Kazama M
Thromb Haemost; 1994 Oct; 72(4):573-7. PubMed ID: 7878635
[TBL] [Abstract][Full Text] [Related]
39. Changes in topoisomerase I levels and localization during myeloid maturation in vitro and in vivo.
Kaufmann SH; Charron M; Burke PJ; Karp JE
Cancer Res; 1995 Mar; 55(6):1255-60. PubMed ID: 7882318
[TBL] [Abstract][Full Text] [Related]
40. Monocytic differentiation of HL-60 promyelocytic leukemia cells correlates with the induction of Bcl-xL.
Chatterjee D; Han Z; Mendoza J; Goodglick L; Hendrickson EA; Pantazis P; Wyche JH
Cell Growth Differ; 1997 Oct; 8(10):1083-9. PubMed ID: 9342186
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
